Cavalier Investments’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,700
Closed -$712K 103
2020
Q1
$712K Hold
9,700
0.42% 57
2019
Q4
$815K Hold
9,700
0.35% 63
2019
Q3
$815K Buy
9,700
+5,000
+106% +$378K 0.35% 63
2019
Q2
$307K Hold
4,700
0.13% 93
2019
Q1
$277K Hold
4,700
0.11% 109
2018
Q4
$249K Buy
+4,700
New +$258K 0.08% 138

Other funds holding MEDP

Cavalier Investments's MEDP Position: Q2 2020 in Review

Cavalier Investments sold out of Medpace (MEDP) in Q2 2020, closing a stake of 9,700 shares — an estimated $712K sold.

Cavalier Investments first reported a position in MEDP in Q4 2018 and held it in 6 quarters. The position peaked at $815K in Q4 2019. 277 funds tracked by Wall St. Rank hold MEDP as of Q2 2020.

  • Cavalier Investments reported no remaining Medpace position as of Q2 2020 after selling out during the quarter.
  • Cavalier Investments sold 9,700 Medpace shares in Q2 2020, an estimated $712K.
  • Cavalier Investments first reported a position in Medpace in Q4 2018 and held it in 6 quarters.
  • Cavalier Investments's Medpace position peaked at $815K in Q4 2019.
  • 277 funds tracked by Wall St. Rank held Medpace as of Q2 2020.

Based on Cavalier Investments's 13F filing for Q2 2020, filed 10 Aug 2020.